Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

A global market access journey in cannabinoid pharmaceuticals

A global market access journey in cannabinoid pharmaceuticals

FromPharma Market Access Insights - from Mtech Access


A global market access journey in cannabinoid pharmaceuticals

FromPharma Market Access Insights - from Mtech Access

ratings:
Length:
54 minutes
Released:
Jun 17, 2023
Format:
Podcast episode

Description

What does it take to bring a cannabinoid pharmaceutical to market?We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the Pharma industry can learn from their journey.In the webinar, Clare asked Michael about:- Drug development and clinical trial processes for medical cannabis products - Differences between the herbal medicines market and the Pharmaceutical market - Overcoming regulatory and reimbursement challenges - Finding the right place for cannabinoid medicines within existing pathways of care - Perceptions, pathways and routes to access in different markets - Lessons for the wider Pharma and Biotech industriesLearn more about this webinar and our guest speaker Michael Sassano at: https://mtechaccess.co.uk/global-market-access-journey-cannabinoid-pharmaceuticals/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
Released:
Jun 17, 2023
Format:
Podcast episode

Titles in the series (56)

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Mtech Access. Our first series focuses on the NHS response to the COVID-19 pandemic.